奥马利祖马布控制了喘中的树突细胞和单细胞的表面表型
Agnes Yang1, Laurie Baert1, Katherine Upchurch2
1Department of Immunology, Mayo Clinic, Scottsdale, Ariz.
The journal of allergy and clinical immunology. Global
|July 23, 2025
概括
奥马利祖马布改变了喘患者的免疫细胞种群,降低了髓状树突细胞 (DC) 频率,并降低了DC和单细胞上的关键表面分子的下调. 这些变化为omalizumab提供了洞察力.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
- 细胞生物学 细胞生物学
背景情况:
- 奥马利祖马布在中度至重度喘中具有临床益处,但其机制尚不清楚.
- 了解奥马利祖马布对免疫细胞的影响对于优化喘治疗至关重要.
研究的目的:
- 调查奥马利祖马布对喘患者血液树突细胞 (DC) 和单细胞子集的频率和表面表型的影响.
- 探索奥马利祖马布治疗的潜在作用机制.
主要方法:
- 在中度至重度喘患者 (n=45) 和非喘对照患者 (n=22) 中对DC和单细胞子集进行纵向流动细胞计分析.
- 从基线到26周进行的分析,评估表面标记物表达和细胞频率.
主要成果:
- 奥马利祖马布通过增加血细胞直流量来降低髓状直流/血细胞直流的比率.
- 观察到FcεRI,HLA-DR,CCR7和DC和单细胞上的共刺激分子的下调.
- 在单细胞上降低了CCR7和HLA-DR,在单细胞上降低了CD88,与喘症状严重程度相关.
结论:
- 奥马利祖马布调节DC和单细胞表型,为其作用机制提供了新的见解.
- 这些发现表明血清IgE在影响喘中的DC和单细胞表面表型方面发挥了作用.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
469
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
469
Antiasthma Drugs: Leukotriene Modifiers
483
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
483
Asthma: Pathogenesis and Management
599
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
599
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
398
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
398
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K


